In humans, elevated circulating resistin levels are significantly related to increased risk of type 2 diabetes [17, 76], while resistin has been implicated in the pathogenesis of obesity-mediated insulin resistance and type 2 diabetes in rodent models [17, 63, 75, 77]. The gene discussed is RETN; the disease is Insulin resistance.